WILLIAMS DOUGLAS E 4
4 · Codiak BioSciences, Inc. · Filed Feb 21, 2023
Insider Transaction Report
Form 4
WILLIAMS DOUGLAS E
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2022-08-16+22,969→ 41,146 total - Sale
Common Stock
2022-08-17$2.21/sh−7,112$15,739→ 34,034 total - Sale
Common Stock
2023-02-17$0.59/sh−7,681$4,549→ 49,322 total - Exercise/Conversion
Restricted Stock Units
2022-08-16−22,969→ 68,906 total→ Common Stock (22,969 underlying) - Exercise/Conversion
Common Stock
2023-02-16+22,969→ 57,003 total - Exercise/Conversion
Restricted Stock Units
2023-02-16−22,969→ 45,937 total→ Common Stock (22,969 underlying)
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a "sell to cover" provision included in the RSU Agreement.
- [F3]Each RSU represents a contingent right to receive one share of common stock.
- [F4]On February 16, 2022, the reporting person was granted 91,875 RSUs, vesting in four equal installments every six months beginning on the six month anniversary of the grant date.